Biochem. J.
177
(1994) 299, 177-181 (Printed in Great Britain)
Biochem. J. (1994) 299, 177-181
(Printed
in
Great
Britain)
Diethyl pyrocarbonate modification of the ryanodine receptor/Ca2+ channel
from skeletal muscle
Varda SHOSHAN-BARMATZ* and Simy WEIL
Department of Life Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel
Exposure ofjunctional sarcoplasmic reticulum (SR) membranes
or purified ryanodine receptor to the histidine-specific reagent
diethyl pyrocarbonate (DEPC) led to concentration- and timedependent inactivation of ryanodine binding. The pH-dependence of the inactivation of ryanodine binding by DEPC and the
reversal of this inactivation by hydroxylamine suggests the
modification of histidine residue(s) by the reagent. Kinetic
analysis of the time course of inactivation of ryanodine binding
by DEPC suggests that the inactivation resulted from modification of a single class of histidine residue per ryanodine-binding
site. The degree of inactivation of ryanodine binding by DEPC
was decreased when high NaCl concentrations were present in
the modification medium. The binding affinities for ryanodine
and Ca2l were not altered by DEPC modification. This modification decreased the total ryanodine-binding sites. DEPC modification increased the Ca2+-permeability of the SR vesicles. A
variety of bivalent cations prevented the DEPC inactivation of
ryanodine binding in a series of decreasing efficiency: Mn2+ >
Ba2l > Mg2+ > Ca2l, similar to their effectiveness in inhibiting
ryanodine binding. It is suggested that a histidine residue(s) in
the ryanodine receptor is involved, either in the binding of Ca2
INTRODUCTION
MnCl2, MgCl2, spermine-agarose and CHAPS were obtained
from Sigma Chemical Co. [3H]Ryanodine (60 Ci/mmol) was
purchased from New England Nuclear. Unlabelled ryanodine
was purchased from Calbiochem.
In muscle cells, Ca2+ release from the sarcoplasmic reticulum
(SR) plays an important role in excitation-concentration coupling [1,2]. A protein involved in the release of Ca2+ to the
myoplasm space has been identified as the target of the toxic
alkaloid ryanodine [3,4]. This protein has been purified and
shown to be a homotetrameric complex [5-7]. It is accepted that
the ryanodine-sensitive Ca2+ channels are a central component of
excitation/contraction coupling in heart and skeletal muscle
[5,8].
The purified ryanodine receptor contains an intrinsic Ca2`
channel activity which is regulated by various modulators such
as caffeine, ATP, calmodulin, Mg2" and Ca2+ [5]. The dependence
of Ca2+ release and ryanodine-binding activities on Ca2+ concentration suggests that the ryanodine receptor/Ca2+-release
channel possesses high-affinity, activating, and low-affinity, inhibitory, Ca2+-binding sites [9-12]. Analysis of the amino acid
sequence of the ryanodine receptor, deduced from the cDNA
sequence, has led to predications of the location of high- and
low-affinity Ca2' binding sites [13-15].
Diethyl pyrocarbonate (DEPC) reacts with histidyl residues in
proteins to yield the N-carbethoxyhistidyl derivative [16]. This
modification can be reversed by the addition of hydroxylamine,
which is specific for the N-carbethoxyhistidyl derivative [16].
DEPC at millimolar concentrations was shown to induce Ca2+
release from SR vesicles [17].
In this study we demonstrate that DEPC modifies a histidyl
residue in the ryanodine receptor, probably at the Ca2+-binding
site(s), and this leads to inhibition of ryanodine binding.
MATERIALS AND METHODS
Materials
ATP, EGTA, EDTA, Tris, Mes, Mops, DEPC, histidine, BaCl2,
,
conformational change that may be required for Ca2+
binding to its binding site(s). This modification of the ryanodine
receptor resulted in inactivation of ryanodine binding and
or
in
a
activation of Ca2+ release.
Membrane preparation
Junctional SR membranes were prepared from rabbit fast-twitch
skeletal muscle as described by Saito et al. [18]. In most of the
experiments the fraction R4 was used. The membranes were
suspended to a final concentration of about 25 mg of protein/ml
in a buffer containing 0.3 M sucrose and 10 mM Tricine, pH 8.0,
and stored at -70 'C.
Purification of the ryanodine receptor
Ryanodine receptor was purified by the spermine-agarose
method [19]. The purified protein (14-50 ,ug/ml) was assayed for
[3H]ryanodine binding (in 0.1 ml) as described below for the
membranes, except that soybean lecithin (0.5 mg/ml) was present
in the assay medium. After 2 h at 30 'C, the bound ryanodine
was assayed by poly(ethylene glycol) 600 precipitation in the
presence of carrier protein (1.4 mg/ml BSA), followed by filtration through Whatmann GF/B filters and washes with 3 x 4 ml
of 10 % poly(ethylene glycol) solution [19]. Protein concentration
of SR membranes was determined as described by Lowry et al.
[20], and that for the purified ryanodine receptor as described by
Kaplan and Pedersen [21].
Modification by DEPC
SR membranes (1-2 mg/ml) or purified ryanodine receptor
(14-50 ,tg/ml) in 50 mM Mes, pH 6.0, were incubated with the
indicated concentration of DEPC at 25 'C for the indicated time.
After quenching the DEPC that had not reacted with 20 mM
histidine, pH 7.0, samples were assayed for ryanodine binding.
Abbreviations used: DEPC, diethyl pyrocarbonate; SR, sarcoplasmic reticulum.
* To whom correspondence should be addressed.
178
V. Shoshan-Barmatz and S. Weil
DEPC stock solutions were prepared by diluting DEPC into dry
acetonitrile immediately before use. The concentration of acetonitrile in control and DEPC-containing samples was 2 % or less.
[3H]Ryanodine binding
Unless otherwise indicated, junctional SR membranes (final
concn. 0.5 mg/ml) were incubated with 20 nM [3H]ryanodine
(sp. radioactivity 30 Ci/mmol) in a standard binding solution
containing 1.0 M NaCl, 20 mM Mops, pH 7.4, and 50 ,uM CaC12,
for 1-2 h at 37 'C. The unbound ryanodine was separated from
the protein-bound ryanodine by filtration of protein samples
(50 ,ug) through Whatmann GF/C filters, followed by washing
with 3 x 5 ml of ice-cold buffer containing 0.2 M NaCl, 5 mM
Mops, pH 7.4, and 50,M CaCl2. The filters were dried, and the
retained radioactivity was determined by liquid-scintillation
counting. Non-specific binding was determined in the presence of
25 ,uM unlabelled ryanodine.
Ca2+ efflux from passively loaded vesicles
SR vesicles were incubated with or without DEPC as described
above, and then the membranes were collected by centrifugation
(40000 g, 30 min). The pellets were resuspended to 3 mg/ml in a
medium containing 0.3 M KCl, 20 mM Mops, pH 6.8, and
0.4 mM CaC12 (containing 45CaC12, 5 x 104c.p.m./nmol) and
incubated for 2 h at 24 'C. For Ca2+-efflux assay, the loaded
vesicles (20 ,ul) were placed on 0.45 ,um-pore nitrocellulose filters
and rinsed with different volumes of 0.3 M KCl/20 mM Mops
(pH 6.8)/i mM EGTA solution for the indicated time. The flow
rate was about 1 ml/s.
Inactivation of ryanodine binding by DEPC as a function of
the pH of the modification medium is shown in Figure 4. As
shown, the degree of inactivation by 0.3 or 0.6 mM DEPC is
markedly decreased at alkaline pH, where the pKa of the reactive
group residue appears to be less than 6.2. These results suggest
that inactivation of ryanodine binding by the reagent is due to
modification of histidyl residue(s). It has been shown that in
phosphate buffer, pH 6.5, DEPC reacts with histidine residues
relatively specifically [16]. It has also been shown, however, that
a thiol such as N-acetylcysteine also reacts with DEPC under
slightly acidic conditions to yield a somewhat unstable product
absorbing at 240 nm, but only in- carboxylate buffers [23].
Therefore, the effect of preincubation of SR with DEPC in
different buffers (Mes, Mops, phosphate) on ryanodine binding
was tested. A similar degree of inhibitiW4-£ ryanodine binding
by DEPC was obtained when the modificatibn was carried out in
the presence of the different buffers at the same pH.
The specific modification of histidine by DEPC could be
0
~120
0
W?100
0
go80
120
(a) SR membranes
80
60
~60
4020
0 40
.0
S20
0
'
(b) Purified RyR
100
-
1
O
3
2
0
1
[DEPCI (mM)
[DEPCI (mM)
Figure 1 Inactivation of ryanodine binding to junctional SR membranes
purEed ryanodine receptor by modMcation with DEPC
and
RESULTS
Ryanodine-binding activity, of either SR membranes or purified
ryanodine receptor, is lost when incubated with relatively low
concentrations of DEPC at pH 6.0. For example, the binding of
ryanodine was completely inhibited when SR membranes were
incubated with 1.0 mM DEPC at 25 'C for 10 min (Figure la).
Similar results were obtained with the purified ryanodine receptor
(Figure Ib). However, as shown in Figure 1(b), the presence of
phospholipids (5 mg/ml) in the modification medium strongly
decreased inactivation of ryanodine binding by DEPC. This may
result from an interaction of DEPC with phospholipids.
Figure 2 shows the time course of inactivation of ryanodine
binding at different DEPC concentrations. The inactivation of
ryanodine binding by DEPC appears to be pseudo-first-order,
with a ti of 3 min in the presence of 1.2 mM DEPC. Since the
inactivation is pseudo-first-order, either a single group or two or
more exactly equivalent groups are probably involved in the
inactivation of ryanodine binding by DEPC. This is also demonstrated in Figure 2(b), where the data were replotted as described
by Levy et al. [22]. The plot of log ti (the time required for 50 %
inhibition of ryanodine binding) as a function of log [DEPC]
yields a straight line with a slope of 0.99 (Figure 2b). These
results are consistent with DEPC modification of a single class of
site and that this modification eliminates ryanodine binding.
Figure 3 shows the effect of NaCl on the inactivation of
ryanodine binding by DEPC when present in the modification
medium. NaCl decreased the inhibition of ryanodine binding by
the reagent. This protection by NaCl may suggest that the
protein conformation(s) stabilized by high salt concentration is
less sensitive to DEPC.
SR membranes (1 mg/ml) (a) or purified ryanodine receptor (14 ,ug/ml) ( b) were incubated
with the indicated concentration of DEPC in 50 mM Mes, pH 6.0. After 10 min incubation at
25 OC, histidine (pH 7.0) was added to a final concentration of 20 mM. Samples were assayed
for ryanodine binding, as described in the Materials and methods section. In (a), 0 and 0
indicate two different experiments of a total of 10 similar experiments, and in (b) 0 indicates
the presence of phospholipids (5 mg/ml) during the incubation with DEPC. Control activities
(100%) were (a) 6.5 (0) and 7.0 (-) and (b) 247 (e) and 395 (0) pmol/mg of protein
for SR and purified ryanodine receptor (RyR) respectively.
1.2 r..
.E 1.04
*i 0.8
Ev
0.6
. 0.4
< 0.2
1.0
(0) (a)
a
c 0.6
0
(1 2)\ (0.8)
(0.4)
0.4
\
0.2
0
7-0.2 0
(b)
0.8
8
12 16
Incubation time (min)
4
20
0
.
I
O .I
-1.0 -0.7 -0.4 -0.1 0.2
0.5
log{[DEPCI (mM))
Figure 2 Time course of DEPC inhiblon of ryanodine binding
SR membranes (1.0 mg/ml) were incubated without (0) or with (0, A, M, a ) different
concentrations of DEPC as described in the Materials and methods section. The reaction was
terminated at various times by addition of histidine, pH 7.0, to a final concentration of 20 mM.
Samples (50 psI) were assayed for ryanodine binding as described in the Materials and methods
section. The half-time for inactivation (ti) was calculated for each DEPC concentration (a).
A double-logarithmic plot of 4, of inactivation against DEPC concentration is shown in (b). The
slope value, n = 0.99 (r = 0.96). The DEPC concentrations used were: 0.2 (A), 0.4 (O),
0.8 (U) and 1.2 mM (0). Control activity (100%) = 10 pmol of ryanodine bound/mg of
protein.
Diethyl pyrocarbonate modification of ryanodine receptor
179
0.1
1
Free Ca2, (,uM)
Figure 3 Effect of NaCI on the Inactivation by DEPC of ryanodine binding
In (a), SR membranes (1 mg/ml) were incubated for 10 min in 50 mM Mes, pH 6.0, with the
indicated concentration of DEPC in the absence (0) or the presence (0) of 0.5 M NaCI. In
(b), SR membranes (1 mg/ml) were incubated for the indicated time with and without 0.4 mM
DEPC in 50 mM Mes, pH 6.0, in the absence (0) or the presence (0) of 0.5 M NaCI. Control
activity (100%) was 8.0 pmol/mg of protein. Ryanodine binding was assayed as described in
the Materials and methods section.
Figure 5 Ca2+-dependency of ryanodine binding by unmodified and DEPCmodmed membranes
Unmodified (@) and DEPC-modified (/,A 0.3 mM; 0, 0.6 mM), membranes were assayed for
ryanodine binding in the presence of 0.2 mM EGTA and the indicated free Ca2+ concentrations.
Free Ca2+ concentration was based on the EGTA association constant reported by Fabiato [31].
0.6
ns
Cop
:
(a)
0
5
.
( b)
2.0
-
E lO
-
2.5
o
~~
~
~
~
~~o
0)
0
5.6
Fiue4
-
6.4 of0
6.0
6.8 - -bn5.6
Hdpnec
ryndn
Preincubation pH
6.0
6.4
6.8
natviobyDP
Preincubation pH
Figure 4 pH-dependence of ryanodine-binding inactivation by DEPC
SR membranes (1.0 mg/ml) were incubated without (@) or with DEPC (0.6 mM; C) at
different pH values as described in the Materials and methods section. The bufters used were:
25 mM Mes for pH 5.8, 6.0, 6.2, 6.4 and 6.8, and 20 mM Mops for pH 6.8 and 7.5. The log
of percentage of activity remaining versus incubation pH is presented in (b).
Table 1 Effect of hydroxylamine treatment on the inhibition of ryanodine
binding by DEPC modification of SR membranes
SR membranes were incubated without or with 0.4 mM DEPC for 10 min (first preincubation),
and then hydroxylamine from a 0.5 M stock solution, pH 7.0, was added to the indicated final
concentrations. After 20 min at 22 °C (second incubation), the samples were centrifuged and
the pellets were resuspended in 0.25 M sucrose/10 mM Tricine (pH 8.0)/1 mM histidine and
assayed for ryanodine binding and protein concentration as described in the Materials and
methods section. Control activity (100%) was 2.2 pmol of ryanodine bound/mg of protein. This
activity is lower than in the other experiments, because of the long period of incubation at
pH 6.0.
Preincubation conditions
Second
First
1. Mes,
2. Mes,
3. Mes,
4. Mes,
5. Mes,
6. Mes,
pH 6.0
pH 6.0
pH 6.0
pH 6.0 + DEPC
pH 6.0 + DEPC
pH 6.0 + DEPC
NH20H (10 mM)
NH2OH (40 mM)
NH20H (10 mM)
NH20H (40 mM)
Ryanodine bound
(% of control)
100
100
137
27
101
126
[Ca2+] (mM)
Figure 6 Effect of CaCI2 on the Inactivation by DEPC of ryanodine binding
SR membranes were incubated without or with DEPC (0.6 mM) in the absence and the presence
of the indicated concentrations of CaCI2 for different times as described in Figure 1. The apparent
first-order inactivation rate of ryanodine binding in the absence (0) and the presence (0) of
different concentrations of Ca2+ is shown. The Ca2+ concentrations used were 0.1, 0.2, 0.4, 0.6
and 1 mM. Inset shows representative time courses of ryanodine-binding inactivation with DEPC
in the absence (0) and the presence of 0.2 mM (A) and 1 mM (0) CaCI2. Ryanodine
binding was assayed as described in the Materials and methods section.
supported by reversal of the inhibition of ryanodine binding by
hydroxylamine [16]. Since hydroxylamine by itself inhibited
ryanodine binding (results not shown), the untreated and DEPCtreated membranes, incubated with hydroxylamine, were washed
with sucrose buffer before the assay of ryanodine binding. Table
1 shows that hydroxylamine treatment of DEPC-modified membranes reverses the inhibition of ryanodine binding.
The following experiments demonstrate that the modification
by DEPC did not change the Ca2+-dependency of the ryanodine
binding, nor the binding affinity of the receptor for ryanodine.
As has been shown previously [5,9,10], ryanodine binding is
Ca2+-dependent (Figure 5). Under the conditions used (1.0 M
NaCl and pH 7.4), the Ca2+-dependency of binding by unmodified and DEPC-modified membranes was similar. The concentration of Ca21 giving half-maximal stimulation (C50) of
ryanodine binding was 150-200 nM Ca2+ (n = 2) in the unmodified or DEPC-modified membranes. However, we found that
DEPC modification decreased the total ryanodine-binding sites
V. Shoshan-Barmatz and S. Weil
180
Table 2 Effect of bivalent cations on the inactivation of ryanodine binding
by DEPC
In Expt. I, SR membranes (1 mg/ml) were incubated at 25 °C in 50 mM Mes, pH 6.0, without
(control) and with DEPC (0.4 mM) and in the presence or the absence of the indicated bivalent
cations. After 10 min of incubation, EDTA and CaCI2 were added to decrease the free metal
concentration and to bring the Ca2+ concentration to about 50 ,uM, and then ryanodine binding
was assayed. In Expt. II, ryanodine binding was assayed in the absence and the presence of
different concentrations of the indicated bivalent cations, as described in the Materials and
methods section, except that the NaCI concentration was 0.2 M. The results are of two different
experiments from which the IC50 and Hill coefficient (h) were obtained. The enhancement of
ryanodine binding in the control by preincubation with CaCI2 or MnCI2 is probably due to their
protection against some inactivation of ryanodine binding caused by the incubation of SR at
acidic pH.
[3H]Ryanodine bound
(pmol/mg of protein)
(% of control)
Bivalent cation present in:
Control
DEPC
Expt. I: Preincubation
None
CaCI2 (0.5 mM)
CaCI2 (1.0 mM)
BaCI2 (0.5 mM)
MgCI2 (0.5 mM)
MgCI2 (1.0 MM)
MnCI2 (0.5 mM)
MnCI2 (1.0 mM)
MnCI2 (3.0 mM)
8.7
12
8.4
8.4
7.8
4.8
12.2
8.5
7.0
1.2
11.2
7.9
4.1
5.3
5.2
5.2
4.4
4.9
15
93
94
49
68
108
43
52
70
IC50 (mM)
h
0.6
0.5
0.25
0.1
0.90
1.03
1.09
0.95
Expt. Il: Ryanodine binding
CaCI2
MgCI2
BaCI2
MnCI2
Figure 6 shows that the presence of CaCl2 during the modification of SR membranes with DEPC protects against the
inactivation of ryanodine binding by DEPC. Ca2+ decreases the
rate of inactivation of ryanodine binding by DEPC (Figure 6). In
Figure 6 a plot of the apparent first-order inactivation rate of
ryanodine binding by DEPC in the absence and the presence of
different Ca2+ concentrations is presented. Ca2+ affords complete
protection, with half-maximal protection obtained at 0.4 mM.
Table 2 shows that not only Ca2+, but also Mg2+, Ba2+ and
Mn2+, all protected against the inactivation of ryanodine binding
by DEPC. Table 2 shows that Ca2+ and other bivalent cations,
when present in the assay medium, inhibited the binding of
ryanodine (Expt. II). The results show a similar order of
effectiveness of the bivalent cations in protection against inactivation of ryanodine binding by DEPC and in inhibition of
ryanodine binding (Table 2). In these experiments we used 0.2 M
NaCl, since high salt concentration (1 M) increases by about 2fold the cation concentration required for 500% inhibition of
ryanodine binding (results not shown).
The effect of DEPC modification on Ca21-permeability of the
SR membranes is shown in Figure 7. As shown, DEPC treatment
activates Ca2' efflux from SR vesicles. SR modification by
increased DEPC concentration enhances both the degree of Ca2+
efflux and the degree of inhibition of ryanodine binding. Similar
results were reported previously with higher DEPC concentrations and actively loaded SR vesicles [17]. We have not tested,
however, whether the membrane permeability for other ions has
not been changed.
The number of histidyl residues reacting with DEPC per
molecule of the purified ryanodine receptor could not be determined, because of the relatively low molar absorption coefficient of the N-carboethoxyhistidyl derivative (3200 M-1. cm-')
[24], and the high molecular mass of the ryanodine receptor.
DISCUSSION
0
0
00
10.
O
4
8
Time (s)
12
16
Figure 7 DEPC-induced Ca2+ efflux from passively loaded SR vesicles
SR membranes untreated (0) or treated with 0.4 mM (-) or 0.8 mM (A) DEPC were loaded
with 45CaCI2 and assayed for Ca2+ efflux as described in the Materials and methods section.
(/) indicates control membranes loaded with 45CaC12 for 90 min and then incubated with
0.5 uM ryanodine for 30 min, before the assay of Ca2+ efflux. Ryanodine-binding activities were
5.2, 2.9 and 2.1 pmol/mg of protein for controls and membranes treated with 0.4 mM or
0.8 mM DEPC respectively. Ca2+ content of the loaded vesicles (100%) was 8 nmol/mg of
protein.
without directly affecting the binding affinity (results not shown).
Thus the C for Ca2+ in both SR preparations is for the
unmodified ryanodine receptor.
The inactivation of ryanodine binding by DEPC shown here
amply substantiates the role of histidyl residues in the binding of
ryanodine to its receptor. Our results indicate that modification
of histidyl residues with DEPC results in a dose-dependent
decrease in specific ryanodine binding to both the membranebound and the soluble, purified, ryanodine receptor (Figure 1).
This decrease is due to a decrease in the number of ryanodinebinding sites, and may suggest that a histidyl residue modified by
DEPC is closely associated with the ryanodine-binding sites.
Studies on the relationship between the ryanodine-binding site
and the DEPC-modification site are difficult, since ryanodine
binds very tightly to its receptor, making meaningful competition
experiments between ryanodine and DEPC impractical. However, since Ca2+ protects against the inactivation of ryanodine
binding by DEPC, it is possible that the alkylated histidyl residue
is involved either in Ca2+ binding to the high- or the low-affinity
sites, or in conformational changes that may occur upon Ca21
binding and which are involved in activation or inactivation of
ryanodine binding. The suggestion that the covalent modification
of the ryanodine receptor by DEPC occurs at, or affects, the
Ca2+-binding site(s) is discussed below.
DEPC reacts with many nucleophiles at pH > 7.0, but it is
specific for the imidazole ring of histidine at pH 6.0 [16]. Although
it has not been demonstrated that the effects of DEPC are due to
modification of ryanodine-receptor histidyl residue(s), several
indirect lines of evidence are consistent with the notion that
DEPC alkylates a histidine moiety. (a) DEPC treatment at
pH < 6.0 specifically modifies histidyl residues in a number of
soluble proteins [16]. The pH-dependence of DEPC inactivation
Diethyl pyrocarbonate modification of ryanodine receptor
(Figure 4) suggests the involvement of reactive group(s) with a
may represent the PKa of the
reactive imidazole group. (b) Hydroxylamine displaces the
ethoxycarbonyl moiety from the imidazole nitrogen of histidine
[16], and regenerates the ryanodine-binding activity of the DEPCmodified membranes (Table 1). (c) It has been shown that
exposure of the SR vesicles to light in the presence of the dye
Rose Bengal, an operation that leads to photo-oxidation of
histidyl residues [25], caused an activation of Ca2+ release and
inhibition of ryanodine binding [17], as well as an activation of
reconstituted Ca2+-release channels [26]. It has been shown also
that illumination of Ca2+-release channels, isolated from sheep
cardiac SR, in the presence of Rose Bengal resulted in the loss of
ryanodine binding and the appearance of channels with subconductance states [27].
Of unique interest is the effect of Ca2+ and other bivalent
PKa value of about 6.2, which
cations
on
the action of DEPC
on
ryanodine receptor. Ca2+
diminished the inactivation of ryanodine binding by DEPC
(Figure 6). Thus a role for histidine residue(s) in the binding of
Ca2+ might be expected, in view of the protection against the
DEPC inactivation of ryanodine binding by Ca2' and several
other bivalent cations. Two types of Ca2+ regulatory sites have
been defined: a lower-affinity inhibitory site, and a higher-affinity
binding site, which activates Ca2+ release [2,11,12] and ryanodine
binding [5,9,10]. The effect of Ca2+ in both the protection against
inactivation of ryanodine binding with DEPC and inhibition of
ryanodine binding can be mimicked by other bivalent cations
such as Ba2+, Mg2+ and Mn2+. These cations do not activate Ca2+
release or ryanodine binding [28]. The activation by Ca2+ is
proposed as being due to the occupation of the high-affinity
binding sites, with a Hill coefficient of about 2.0. The inhibition
of ryanodine binding by these cations, together with their Hill
coefficient of about 1.0 obtained for the inhibitory effect (Table
2), suggest that these cations probably occupied the low-affinity
binding site(s) responsible for inactivation of Ca2+-releasechannel activity. Thus we suggest that the protection afforded by
the bivalent cations against the inactivation of ryanodine binding
by DEPC is due to the occupation of the low-affinity binding site
by these cations. Protection against DEPC modification by Ca2+
or other bivalent cations suggests that the binding of Ca2+ results
in a change in the environment of the histidyl residue attacked by
DEPC. The protection is either directly due to steric hindrance,
i.e., Ca2+ and DEPC bind at the same site in the ryanodine
receptor, or indirectly due to a Ca2+-induced change in protein
conformation, which alters the reactivity of the histidyl residue.
The observation that Ca2+ efflux from Rose-Bengal-modified
membranes was not inhibited by millimolar Mg2+[17], assuming
that it modifies the same histidyl residue, supports our suggestion
that the modified histidyl residue is located in the inhibitory, lowaffinity, bivalent-cation-binding site(s).
In several cation-binding proteins the histidyl residues are
directly involved in the ligation of cations to form important
hydrogen bonds with carboxylic groups. For example, Zn in the
active site of human carbonic anhydrase is tetrahedrally coordinated by three histidine side chains and a H20 molecule [29],
and Cu ions in cytochrome oxidase are bonded to a histidine
side chain [30].
Received 4 October 1993/23 November 1993; accepted 1 December 1993
181
In conclusion, our results show that DEPC modification of SR
membranes results in diminished ryanodine binding and opening
of the Ca2l-release channel. It seems possible that this modification stabilizes an open protein conformational state that does
not bind ryanodine. If, as suggested, DEPC modifies the lowaffinity Ca2l-binding site(s) on the ryanodine receptor, it may
serve as a useful probe to localize these sites, and to help to
elucidate their involvement in the control of channel gating.
The work was supported by grants from the Chief Scientist's Office, Ministry of
Health, Israel, and by the fund for basic research administered by the israeli Academy
of Science and Humanities. We thank Professor J. Abramson, Portland State
University, for reading the manuscript and offering helpful discussions and valuable
suggestions.
REFERENCES
1 Endo, M. (1977) Physiol. Rev. 57, 71-108
2 Martonosi, A. N. (1984) Physiol. Rev. 64, 1240-1319
3 Fleischer, S., Ogunbunmi, E. M., Dixon, M. C. and Fleer, E. A. M. (1985) Proc. Natl.
Acad. Sci. U.S.A. 82, 7256-7259
4 Pessah, I. N., Francini, A. O., Scales, D. J., Waterhouse, A. L. and Casida, J. E.
(1986) J. Biol. Chem. 261, 8643-8648
5 Lai, F. A. and Meissner, G. (1989) J. Bioenerg. Biomembr. 21, 227-245
6 lnui, M., Saito, A. and Fleischer, S. (1987) J. Biol. Chem. 262, 15637-15642
7 Lai, F. A., Erickson, H. P., Rousseau, E., Liu, Q.-Y. and Meissner, G. (1988) Nature
(London) 331, 315-319
8 Smith, J. S., Imagawa, T., Ma, J., Fill, M., Campbell, K. P. and Coronado, R. (1988)
J. Gen. Physiol. 92, 1-26
9 Pessah, I. N., Waterhouse, A. L. and Casida, J. E. (1985) Biochem. Biophys. Res.
Commun. 128, 449-456
10 Michalak, M., Dupraz, P. and Shoshan-Barmatz, V. (1988) Biochim. Biophys. Acta
939, 587-594
11 Meissner, G. (1984) J. Biol. Chem. 259, 2365-2371
12 Ma, J. J., Fill, M., Knudson, M., Campbell, K. P. and Coronado, R. (1988) Science
242, 99-102
13 Takeshima, H., Nishimura, S., Matsumoto, T., Ishida, H., Kangawa, K., Minamino, N.,
Matsuo, H., Ueda, M., Hanaoka, M., Hirose, T. and Numa, S. (1989) Nature
(London) 339, 439-445
14 Chen, S. R. W., Zhang, L. and MacLennan, D. H. (1992) J. Biol. Chem. 267,
23318-23326
15 Zorzato, E., Fujii, J., Otsu, K., Green, N. M., Lai, F. A., Meissner, G. and MacLennan,
D. H. (1990) J. Biol. Chem. 265, 2244-2256
16 Miles, E. W. (1977) Methods Enzymol. 47, 431-442
17 Stuart, J., Pessah, I. N., Favero, T. G. and Abramson, J. J. (1992) Arch. Biochem.
Biophys. 292, 512-521
18 Saito, A., Seiler, S., Chu, A. and Fleischer, S. (1984) J. Cell Biol. 99, 875-885
19 Shoshan-Barmatz, V. and Zarka, A. (1992) Biochem. J. 285, 61-64
20 Lowry, 0. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J. (1951) J. Biol. Chem.
193, 265-275
21 Kaplan, R. S. and Pedersen, F. L. (1985) Anal. Biochem. 150, 95-104
22 Levy, H. M., Leber, P. D. and Ryan, E. M. (1963) J. Biol. Chem. 238, 3654-3659
23 Garrison, C. K. and Himes, R. H. (1975) Biochem. Biophys. Res. Commun. 67,
1251-1255
24 Ovadi, J., Libor, S. and Elodi, P. (1967) Acta Biochim. Biophys. Acad. Sci. Hung. 2,
455-458
25 Yu, B. P., Masoro, E. J. and Bertrand, H. A. (1974) Biochemistry 13, 5083-5087
26 Xiong, H., Buck, E., Stuart, J., Pessah, I. N., Salama, G. and Abramson, J. J. (1992)
Arch. Biochem. Biophys. 292, 522-528
27 Holmberg, S. R. M., Cumming, D., Kusama, Y., Hearse, D. J., Poole-Wilson, P. A.,
Shattock, M. J. and Williams, A. J. (1991) Cardioscience 2, 19-25
28 Meissner, G. and El-Hashem, A. (1992) Mol. Cell. Biochem. 114,119-123
29 Sheridan, R. P. and Allen, L. C. (1981) J. Am. Chem. Soc. 103, 1544-1550
30 Scott, R. A. (1989) Annu. Rev. Biophys. Chem. 18, 137-158
31 Fabiato, A. (1988) Methods Enzymol. 157, 378-417